SMS Pharmaceuticals gets CEP approval for Ibuprofen

22 Jul 2022 Evaluate

SMS Pharmaceuticals has received Certificate of Suitability (CEP) approval for Ibuprofen from the European Directorate for the Quality of Medicines & HealthCare (EDQM). With this, the company can start selling Ibuprofen in the European markets. The company will continue to explore avenues to further grow the revenue from Ibuprofen.

The company’s growth trajectory is expected to accelerate further, in the upcoming quarters underpinned by the recovery in the key products and further geographic expansion for Ibuprofen and other products. The Company is committed to meeting the highest quality standards and is further committed to be fully compliant with the GMP regulations at all its manufacturing facilities.

SMS Pharmaceuticals is a global player in API and intermediates manufacturing having a strong research and manufacturing team supported by state?of?the?art facilities.

SMS Pharmaceuticals Share Price

305.55 2.70 (0.89%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×